| Primary |
| Hyperkalaemia |
30.8% |
| Blood Potassium Increased |
13.8% |
| Product Used For Unknown Indication |
13.8% |
| Multiple Myeloma |
7.7% |
| Renal Transplant |
4.6% |
| Asthma |
3.1% |
| Prophylaxis Against Transplant Rejection |
3.1% |
| Renal Failure Chronic |
3.1% |
| Wheezing |
3.1% |
| Antifungal Prophylaxis |
1.5% |
| Antiviral Prophylaxis |
1.5% |
| Back Pain |
1.5% |
| Blood Pressure Management |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Gastrointestinal Motility Disorder |
1.5% |
| Hepatitis |
1.5% |
| Ileus |
1.5% |
| Pain |
1.5% |
| Pyrexia |
1.5% |
| Sedation |
1.5% |
|
| Sepsis |
24.1% |
| Blood Creatinine Increased |
6.9% |
| General Physical Health Deterioration |
6.9% |
| Rectal Ulcer |
6.9% |
| Colitis |
3.4% |
| Confusional State |
3.4% |
| Dehydration |
3.4% |
| Diarrhoea |
3.4% |
| Drug Dispensing Error |
3.4% |
| Hypokalaemia |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Intestinal Mass |
3.4% |
| Laboratory Test Abnormal |
3.4% |
| Large Intestinal Ulcer |
3.4% |
| Medication Error |
3.4% |
| Mucosal Ulceration |
3.4% |
| Muscular Weakness |
3.4% |
| Necrotising Colitis |
3.4% |
| Pain |
3.4% |
| Peritoneal Disorder |
3.4% |
|
| Secondary |
| Blood Potassium Increased |
10.9% |
| Therapeutic Agent Toxicity |
10.1% |
| Drug Use For Unknown Indication |
9.2% |
| Prophylaxis Against Transplant Rejection |
8.4% |
| Renal Transplant |
7.6% |
| Type 2 Diabetes Mellitus |
5.9% |
| Bipolar Disorder |
5.0% |
| Congestive Cardiomyopathy |
5.0% |
| Hypertension |
5.0% |
| Antifungal Prophylaxis |
4.2% |
| Antiviral Prophylaxis |
4.2% |
| Hyperkalaemia |
4.2% |
| Cardiovascular Disorder |
3.4% |
| Epilepsy |
3.4% |
| Hypoaldosteronism |
3.4% |
| Wheezing |
3.4% |
| Blood Pressure Management |
1.7% |
| Diabetes Insipidus |
1.7% |
| Hypertriglyceridaemia |
1.7% |
| Hyperuricaemia |
1.7% |
|
| Sepsis |
30.8% |
| Therapeutic Agent Toxicity |
15.4% |
| Bladder Cancer |
5.1% |
| Colon Adenoma |
5.1% |
| Colon Cancer |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Weight Decreased |
5.1% |
| Blood Pressure Systolic Increased |
2.6% |
| Drug Ineffective |
2.6% |
| Hypertension |
2.6% |
| Interstitial Lung Disease |
2.6% |
| Middle Insomnia |
2.6% |
| Myopathy |
2.6% |
| Product Deposit |
2.6% |
| Rash Maculo-papular |
2.6% |
| Tachypnoea |
2.6% |
| Tearfulness |
2.6% |
| Weight Increased |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.6% |
| Product Used For Unknown Indication |
23.6% |
| Hypertension |
6.2% |
| Prophylaxis |
5.5% |
| Rheumatoid Arthritis |
5.4% |
| Gastric Ulcer |
3.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
| Renal Transplant |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Diarrhoea |
2.2% |
| Infection Prophylaxis |
2.1% |
| Pain |
2.0% |
| Cardiovascular Event Prophylaxis |
1.8% |
| Diabetes Mellitus |
1.7% |
| Angiogram |
1.5% |
| Coronary Artery Disease |
1.5% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Decreased Appetite |
1.4% |
| Hepatic Neoplasm Malignant |
1.4% |
| Hyperparathyroidism Secondary |
1.3% |
|
| Renal Failure |
12.8% |
| Vomiting |
10.3% |
| Ureteric Stenosis |
8.3% |
| Left Ventricular Dysfunction |
7.7% |
| Rhabdomyolysis |
6.4% |
| Nausea |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Myopathy |
4.5% |
| Urinoma |
4.5% |
| Hyperkalaemia |
3.8% |
| Neutropenia |
3.8% |
| Renal Failure Chronic |
3.8% |
| Death |
3.2% |
| Nephrogenic Systemic Fibrosis |
3.2% |
| Pulmonary Oedema |
3.2% |
| Renal Failure Acute |
3.2% |
| Respiratory Failure |
3.2% |
| Conjunctivitis |
2.6% |
| Inappropriate Antidiuretic Hormone Secretion |
2.6% |
| Muscular Weakness |
2.6% |
|
